Translating Systems Medicine Into Clinical Practice: Examples From Pulmonary Medicine With Genetic Disorders, Infections, Inflammations, Cancer Genesis, and Treatment Implication of Molecular Alterations in Non-small-cell Lung Cancers and Personalized Medicine
Non-small-cell lung cancers (NSCLC) represent 85% of all lung cancers, with adenocarcinoma as the most common subtype. Since the 2000's, the discovery of molecular alterations including epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) rearrangements togethe...
Main Authors: | Julian Pinsolle, Anne McLeer-Florin, Matteo Giaj Levra, Florence de Fraipont, Camille Emprou, Elisa Gobbini, Anne-Claire Toffart |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-10-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmed.2019.00233/full |
Similar Items
-
Advances and Therapeutic Perspectives in Extended-Stage Small-Cell Lung Cancer
by: Thomas Pierret, et al.
Published: (2020-11-01) -
Immunotherapy in NSCLC Patients With Brain and Leptomeningeal Metastases
by: Thomas Pierret, et al.
Published: (2022-04-01) -
Implementing ctDNA Analysis in the Clinic: Challenges and Opportunities in Non-Small Cell Lung Cancer
by: Elisa Gobbini, et al.
Published: (2020-10-01) -
Partial response of pulmonary adenocarcinoma with symptomatic brain metastasis to nivolumab plus high-dose oral corticosteroid: a case report
by: Hélène Pluchart, et al.
Published: (2017-07-01) -
Altered splicing of ATG16‐L1 mediates acquired resistance to tyrosine kinase inhibitors of EGFR by blocking autophagy in non‐small cell lung cancer
by: Anne‐Sophie Hatat, et al.
Published: (2022-10-01)